×
CORD is a UK-listed investment trust focused on digital infrastructure, while ZBAO is a China-based digital insurance (insurtech) brokerage business. The two companies operate in entirely different sectors, regions, and risk profiles, making this a contrast between defensive infrastructure income and higher-beta growth exposure.
NCPL is a U.S. fintech shifting toward blockchain and tokenized assets, while ZBAO is a China-based InsurTech (insurance technology) broker scaling digital embedded insurance. Both are small-cap, low-priced, and speculative, but their businesses, growth drivers, and risk profiles differ sharply.
LQDA is a U.S. biopharmaceutical company whose shares recently rebounded sharply after a patent settlement removed a major legal overhang on its lead drug, YUTREPIA. ZBAO is a Chinese InsurTech (insurance technology) firm navigating extreme microcap volatility, a Bitcoin-funded capital raise, and Nasdaq listing-compliance measures.
GENK is a U.S.-listed Asian casual dining operator facing declining same-store sales but pursuing a consumer packaged goods (CPG) expansion. ZBAO is a China-based digital insurance brokerage and insurtech platform with a fundamentally different revenue model and risk profile.
Alaunos Therapeutics (TCRT) is a pre-revenue biotechnology company whose recent acquisition of Velaris Therapeutics functioned as a reverse merger, bringing a pulmonary-focused pipeline and a $350 million private placement. Zhibao Technology (ZBAO) is a Shanghai-based digital insurance broker (InsurTech) that grew half-year revenue 41% but has pivoted aggressively toward a Bitcoin treasury strategy.
Different business models: GRML is a rare-earth and precious-metals explorer tied to Greenland's critical-minerals momentum, while ZBAO operates in China's digital insurance space. Contrasting catalysts: GRML's recent price action has been driven by Greenland-focused geopolitical and funding headlines; ZBAO's trajectory reflects the broader Chinese insurtech and digital insurance environment.
MaxCyte (MXCT) is a cell-engineering platform company, while Zhibao Technology (ZBAO) is a China-based InsurTech (insurance technology) firm, putting the two in entirely different sectors and risk profiles. MaxCyte reported lower 2025 revenue but maintains a large cash balance and a visible pipeline of cell-therapy licensing partners; Zhibao is growing revenue but remains unprofitable with a comparatively thin cash position.
Different business models: YRD (Yiren Digital) is a diversified, AI-powered Chinese financial services platform, while ZBAO (Zhibao Technology) is a niche digital insurance broker built on a "2B2C" (to-business-to-customer) embedded insurance model. Diverging earnings trajectories: YRD swung to a large fourth-quarter loss and suspended its dividend, whereas ZBAO reported strong revenue growth but only marginal net income.
NIVF (NewGenIVF Group) and ZBAO (Zhibao Technology) are both Nasdaq-listed micro-cap stocks with elevated volatility and recent trading halts, making them more suited to risk-tolerant traders than to conservative investors. The two companies operate in fundamentally different industries: NIVF is pivoting from assisted-reproductive services into real estate, digital assets, and artificial intelligence, while ZBAO is a China-based digital insurance brokerage (insurtech) platform.
BSP is a newly listed Italian technology company trading at a large-cap valuation, while ZBAO is a micro-cap Chinese InsurTech firm that has lost most of its value over the past year. The two names differ sharply in scale, sector exposure, and risk profile, making this a contrast between a high-profile growth IPO (initial public offering) and a small-cap turnaround story.
AMTD is a diversified financial and digital solutions conglomerate trading at a sharp discount to its reported book value, while ZBAO is a China-based digital insurance platform posting revenue growth alongside recurring net losses. Both stocks are highly volatile micro-caps, but they occupy unrelated industries and face very different risk profiles.
GLND is an early-stage oil and gas exploration company targeting East Greenland's Jameson Land Basin, while ZBAO is a China-based provider of digital insurance brokerage and underwriting services. The two companies operate in entirely different industries, making this a contrast in sector exposure, growth drivers, and risk profiles rather than a like-for-like business comparison.
TC (Token Cat Limited, formerly TuanChe Limited) is a Chinese omni-channel automotive marketplace that has reported a sharp contraction in revenue in its most recent fiscal year. ZBAO (Zhibao Technology Inc.) is a Shanghai-based InsurTech broker that grew revenue roughly 41% year over year in its latest half-year period, yet remains unprofitable.
Treasure Global (TGL) is a Southeast Asia–focused payment and e-commerce operator, while Zhibao Technology (ZBAO) is a China-based digital insurance technology (insurtech) company. TGL has reported rapid revenue growth but remains unprofitable and has experienced extreme share-price volatility, including a sharp recent decline from its 52-week highs.
Antelope Enterprise Holdings ( AEHL ) is a China-based livestreaming e-commerce and consulting firm; Zhibao Technology ( ZBAO ) is a Shanghai-based digital insurance brokerage. Both are Nasdaq-listed micro-cap stocks that have experienced steep 52-week declines, making them high-volatility, speculative names rather than established holdings.
MGOL (MGO Global Inc.) completed a business combination with maritime firm Heidmar, after which the combined entity began trading under the new ticker HMR ; the legacy MGOL listing was subsequently suspended. ZBAO (Zhibao Technology Inc.) is an actively trading Chinese InsurTech company that has generated multiple catalysts, including a Bitcoin treasury strategy and a recently announced reverse stock split.
AIXI is Xiao-I Corporation, a Chinese cognitive-intelligence and enterprise AI solutions provider; ZBAO is Zhibao Technology, a Chinese InsurTech (insurance technology) firm operating a digital insurance brokerage. Both are Nasdaq-listed, China-based issuers that recently completed reverse share splits to support Nasdaq minimum price compliance.
Bumble ( BMBL ) has pivoted sharply toward a take-private transaction, agreeing to an all-cash acquisition by Ithaca Holdings that has repriced the stock around a defined cash offer. Zhibao Technology ( ZBAO ) is a China-based InsurTech (insurance technology) company pursuing a dual growth and digital-asset strategy, including a Bitcoin treasury and a 1-for-50 reverse share split.
Different business models: FLYE is a U.S.-based electric mobility retailer, while ZBAO is a China-based digital insurance brokerage. Both are deeply beaten-down micro-caps: each has fallen more than 80% over the trailing 52 weeks amid severe volatility and listing-compliance challenges.
PFAI (Pinnacle Food Group) is an early-stage smart-farming and bio-engineering company, while ZBAO (Zhibao Technology) is a China-based digital insurance brokerage, or InsurTech, firm — two very different risk profiles. Both names are micro-cap and volatile, but their recent price trajectories have diverged sharply, with ZBAO under acute listing-compliance pressure.